Gemfibrozil and hepatic enzyme increased Patient Reports February 10, 2012

Gemfibrozil Side Effects Report #5737943-2
Gemfibrozil side effect was reported by a Pharmacist from UNITED STATES on May 12, 2008. Male patient, 67 years of age, weighting 218.3 lb, was diagnosed with hyperlipidaemia and was treated with Gemfibrozil. After drug was administered, patient experienced the following side effects: arthralgia, blood creatine phosphokinase increased, blood triglycerides increased, hepatic enzyme increased, muscular weakness, myalgia, renal failure acute. Gemfibrozil dosage: 600 MG BID PO. During the same period patient was treated with SIMVASTATIN. Patient was hospitalized and became disabled. Patient recovered.

Gemfibrozil Side Effects Report #5481297-6
Gemfibrozil side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 05, 2007. Male patient, 58 years of age, weighting 145.9 lb, was diagnosed with hyperlipidaemia, aplastic anaemia and was treated with Gemfibrozil. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, haemorrhage, headache , hepatic enzyme increased, musculoskeletal stiffness, myalgia, pyrexia. Gemfibrozil dosage: 600MG BID PO. During the same period patient was treated with CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Gemfibrozil Side Effects Report #4644582-3
Gemfibrozil side effect was reported by a Pharmacist from on Apr 25, 2005. Female patient, 44 years of age, was diagnosed with hyperlipidaemia and was treated with Gemfibrozil. After drug was administered, patient experienced the following side effects: hepatic enzyme increased. Gemfibrozil dosage: 600MG BID PO. Patient recovered.

Gemfibrozil Side Effects Report #5688350-2
Gemfibrozil side effect was reported by a Pharmacist from UNITED STATES on Mar 28, 2008. Male patient, 59 years of age, was treated with Gemfibrozil. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, dysstasia, hepatic enzyme increased, muscular weakness, myalgia. Gemfibrozil dosage: unknown. During the same period patient was treated with SIMVASTATIN. Patient was hospitalized. Patient recovered.